基因测试跨过多变性心肌病的表型
Aakash Bavishi1, Kutaiba Nazif2, Matthew W Martinez2
1University of Illinois Chicago, Chicago, Illinois, USA.
JACC. Case reports
|January 30, 2026
概括
超性心肌病 (HCM) 显示了不同的临床结果,尽管在家庭内相同的基因突变. 这凸显了对HCM患者进行基因检测和个性化风险评估的需要.
科学领域:
- 心血管遗传学 心血管遗传学
- 遗传疾病研究 遗传疾病研究
- 临床案例研究 临床案例研究
背景情况:
- 增高性心肌病 (HCM) 是一种遗传性疾病,其特点是可变的透度和表达力.
- 具有相同突变的HCM患者的临床表现可以从无症状到突然心脏死亡.
- 了解对HCM表型的遗传影响对于患者管理至关重要.
研究的目的:
- 报告父子对具有相同的HCM致病突变但临床表型不同的父子对.
- 强调基因检测在HCM诊断和风险分层中的作用.
- 探索HCM单基模型的局限性,并提出一种内基类型的方法.
主要方法:
- 对三个父子对进行案例系列分析.
- 在受影响个体中识别相同的致病性sarcomere基因突变.
- 家庭成员之间的临床表现和表型的比较.
主要成果:
- 这三对父亲和儿子都有相同的HCM遗传突变.
- 在父亲和儿子之间观察到临床表型和疾病严重程度的显著变化.
- 这些发现表明,在家族性HCM中,基因型和表型之间存在差异.
结论:
- 同样的HCM突变不能保证家族内具有相似的临床结果.
- 基因检测对于识别HCM和告知风险分层是必不可少的.
- 一个内基类型模型可能比纯单基模型更好地捕捉HCM的复杂性.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
486
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
486
Cardiomyopathy II: Dilated Cardiomyopathy
563
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
563
Cardiomyopathy IV: Restrictive Cardiomyopathy
532
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care
442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification
603
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
603
Cardiomyopathy VI: Nursing Management
354
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
354


